Vistagen Therapeutics Inc. (VTGN)
NASDAQ: VTGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
VTGN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $10.97M
- EPS (TTM)
- -$1.66
- Dividend yield
- None
- 52-week range
- 0.20 – 5.14
- Day range
- 0.2424 – 0.2567
- Volume / Avg
- 771.44K / 12.40M
- Beta
- —
- Shares outstanding
- 44.38M
52-week range
VTGN stock today
On Oct 7, VTGN ended the session at $0.2471, shedding $0.0035 (1.40%), versus the S&P 500's 0.22% decline. Trading was light, with 771.44K shares changing hands, about 6% of the average daily volume. Shares are 95.2% below their 52-week high of $5.14, set on Nov 24, 2025 and 23.5% above the 52-week low of $0.20, near the bottom of the past year's range.
VTGN is down 62.6% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 93.8%. Vistagen Therapeutics has posted a net loss over the last twelve months (EPS of -$1.66), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Vistagen Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Vistagen Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GTBPGT Biopharma Inc. | 6.20 | -2.67% | $11.19M | vs VTGN |
| KPRXKiora Pharmaceuticals Inc. | 2.53 | +1.20% | $11.19M | vs VTGN |
| BLRXBioLineRx Ltd. ADR | 2.21 | -3.80% | $10.98M | vs VTGN |
| MDCXMedicus Pharma Ltd. | 0.1602 | +0.63% | $11.49M | vs VTGN |
| TOVXTheriva Biologics Inc. | 0.234 | +5.41% | $10.74M | vs VTGN |
| APUSApimeds Pharmaceuticals US Inc. | 7.05 | -1.12% | $10.64M | vs VTGN |
| PHIOPhio Pharmaceuticals Corp. | 0.9995 | +0.51% | $11.61M | vs VTGN |
| GDTCCytoMed Therapeutics Limited | 0.98 | +5.40% | $11.70M | vs VTGN |
Indexes, lists and sector
Vistagen Therapeutics stock FAQ
What is Vistagen Therapeutics's stock price today?
VTGN last traded at $0.2471 as of Oct 7, 4:00 PM EDT, down 1.40% on the day. Prices are delayed at least 15 minutes.
Does Vistagen Therapeutics pay a dividend?
No. Vistagen Therapeutics does not currently pay a regular cash dividend.
Has VTGN ever split its stock?
Yes. The most recent VTGN stock split was a 1-for-30 split on Jun 7, 2023, one of 2 splits on record.
What is the VTGN 52-week high?
The 52-week high for VTGN is $5.14 and the 52-week low is $0.20. The stock is currently 95.2% below its high.